Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Remdesivir in treatment of COVID-19
IRCT20210324050760N1Phase 4Completed
- Sponsor
- Shahrekord University of Medical Sciences
- Start
- Apr 2021
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of remdesivir in coronavirus disease 2019 (COVID-19), sponsored by Shahrekord University of Medical Sciences. Started Apr 2021; status: completed.
02
Drugs
remdesivir
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on IRCT20210324050760N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20210324050760N1.